-+ 0.00%
-+ 0.00%
-+ 0.00%
Heyuan Biotech announced that the implementation period of the company's share repurchase plan is from November 6, 2026 to February 5, 2027. It plans to use 25 million yuan to 50 million yuan to repurchase shares to protect the company's value and shareholders' rights. The repurchase price is not higher than 9.00 yuan/share. On November 19, 2026, the company repurchased 398.1 million shares for the first time through centralized bidding, accounting for 0.6134% of the total share capital. The repurchase price range was 5.71 yuan/share - 5.99 yuan/share, with a cumulative payment amount of 235.151 million yuan.
Share
Listen to the news
Heyuan Biotech announced that the implementation period of the company's share repurchase plan is from November 6, 2026 to February 5, 2027. It plans to use 25 million yuan to 50 million yuan to repurchase shares to protect the company's value and shareholders' rights. The repurchase price is not higher than 9.00 yuan/share. On November 19, 2026, the company repurchased 398.1 million shares for the first time through centralized bidding, accounting for 0.6134% of the total share capital. The repurchase price range was 5.71 yuan/share - 5.99 yuan/share, with a cumulative payment amount of 235.151 million yuan.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending